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The  involvement  of patients  and  the  public  in  healthcare  decisions  becomes  increasingly  important.
Although  patient  involvement  on  the level  of the individual  patient-healthcare  worker  relationship  is
well  studied,  insight  in the  process  of  patient  and  public  involvement  on  a more  strategic  level  is limited.
This  study  examines  the  involvement  of  patient  and  public  (PPI)  in decision-making  concerning  policy
in  six Flemish  hospitals.  The  hospitals  organized  a stakeholder  committee  which  advised  the hospital  on
strategic  policy  planning.  A three-phased  mixed-  methods  study  design  with  individual  questionnaires
(n  =  69),  observations  (n =  10)  and focus  groups  (n  = 4)  was  used  to  analyze,  summarize  and  integrate  the
ﬁndings.  The  results  of this  study  indicate  that:  (1)  PPI on hospital  level  should  include  the possibility  to
choose  topics,  like operational  issues;  (2)  PPI-stakeholders  should  be  able  to have  proper  preparation;  (3)ommunity participation
uality of healthcare
PPI-stakeholders  should  be externally  supported  by  a patient  organization;  (4)  more  autonomy  should  be
provided  for  the  stakeholder  committee.  Additionally,  the  study  indicates  that the  inﬂuence  of  national
legislation  on  stakeholder  initiatives  in  different  countries  is limited.  In combination  with  the growing
importance  of PPI  and  the  fact  that  the  recommendations  presented  are  not claimed  to  be exhaustive,
more  transnational  and conceptual  research  is  needed  in the  future.
© 2018  Elsevier  B.V.  All  rights  reserved.. Introduction
In the declaration of Alma Ata [1], the right and duty of pub-
ic involvement in the planning of healthcare was emphasized. In
he decades to follow, patient and public involvement (PPI) has
ad a rising importance in healthcare [2,3]. Due to demographic
nd epidemiological transitions, PPI has gained even more impor-
ance [4]. Because of an aging population and the upsurge of chronicPlease cite this article in press as: Malfait S, et al. Patient and public i
for effective participation. Health Policy (2018), https://doi.org/10.101
llnesses, healthcare costs are increasing and shifting. This ﬁnan-
ial pressure, in combination with societal expectations, demands
rofound changes in healthcare systems around the world
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168-8510/© 2018 Elsevier B.V. All rights reserved.concerning efﬁciency, efﬁcacy and legitimacy [5,6]. Patient and
public involvement could be one of the possible solutions. There
are indications that PPI increases quality of care [7–9] and trans-
parency and legitimacy about public funds [3], contributing to the
future sustainability of healthcare systems [10]. Evidence increas-
ingly supports the important role of involving patients on all levels
of healthcare systems [6,11–13]: the individual level of the patient-
healthcare worker relationship (micro-level), the collective levels
of wards, patient organizations and hospitals (meso-level), and the
national or international level (macro-level).
Statements that deﬁne PPI as the “holy grail of healthcare” [14]
and “the blockbuster drug of the century” [15], indicate increased
interest in the matter. This movement, which is led by good
intentions, contrasts with the current lack of research on the imple-
mentation of PPI on the more collective level [7,16], also deﬁned
as consumer and community engagement in healthcare systems
[17]. Different to patient involvement on the individual level, whichnvolvement in hospital policy-making: Identifying key elements
6/j.healthpol.2018.02.007
has been more extensively studied across healthcare professions
[18,19], the implementation and impact of consumer and commu-
nity engagement in healthcare systems is understudied [3,20,21].
In the corporate industry, developing strategies to effectively deal
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ith the concerns of stakeholders like consumers and the com-
unity, is a key component of the so called “stakeholder theory”
22]. This theory contrasts to the traditional view of a company,
he shareholder view, in which only the owners or the sharehold-
rs are considered important as the purpose of the company is
o create value for the shareholders. The stakeholder theory is
ew to non-proﬁt healthcare systems and lacks an adapted con-
eptual framework, leaving the dynamics are poorly understood
16,23]. Research on ethical issues concerning consumer and com-
unity engagement in healthcare systems, like the burden for
atients and ﬁnding adequate representation [19,24–27], is needed
28]. Such elements are important for regarding the public and
atients as experts [28,29]. The combination of the lack of evidence
nd the increase in initiatives emphasizes the need for research
n consumer and community engagement in healthcare systems,
ddressed more speciﬁcally in this study in hospital policy-making
16,20].
.1. The Flemish pilot study
In contrast to surrounding countries, PPI in hospital policy in
elgium and Flanders is a new concept and lacks a model adjusted
o the national legislation. Germany [30], France [31], the United
ingdom [15] and the Netherlands [32] have examples of legally
egulated PPI-structures. Because of the speciﬁcity of the health-
are system in Belgium, a new model was developed [33] and
mplemented for a pilot study of two years [29]. In the model, PPI-
takeholders, internal stakeholders (e.g. hospital employees and
embers of the board), and professional external stakeholders (e.g.
nsurance companies or primary healthcare workers) are assem-
led in a stakeholder committee led by an independent president
nd a secretary. The group of PPI-stakeholders was  composed of
atients, their family members, and patient representatives. The
PI-stakeholders were supported by the Flemish Patient Organi-
ation, an independent umbrella-organization for all patient peer
upport groups in Flanders which also professionalizes patient rep-
esentatives. Ideally, an equal number of all stakeholder groups
as represented. The goal of the stakeholder committee was to
iscuss and advice on the annual report, the strategic options and
he hospital business plan. These three elements are seen as the
eading mandatory documents for hospital policy in Belgian and
lemish hospital legislation. Next to these topics, all stakeholders
ad the opportunity to propose new topics for the agenda. A codePlease cite this article in press as: Malfait S, et al. Patient and public i
for effective participation. Health Policy (2018), https://doi.org/10.101
or interactions between the stakeholder committee and the board
f directors was also established. The stakeholder committee had
ix annual meetings. The model was described in more detail by
alfait et al. [29].of this study, based on Addo et al. [36].
2. Materials and methods
2.1. Aim
This study aims to identify conditions that contribute to the
actual involvement of patients and the public in the decision-
making processes of hospital policy through a stakeholder
committee.
2.2. Study design
A three-phased sequential exploratory mixed-methods was
used [34]. In mixed-methods research quantitative and qualita-
tive research methods are combined and integrated to answer
a research question. This leads to triangulation, completeness,
explanation and interpretation of the ﬁndings [35]. Three research
methods were used: questionnaires, observations, and focus
groups. Fig. 1 provides an outline of the study.
2.3. Materials and data analysis
In the ﬁrst phase a questionnaire was used to identify the
opinions of the stakeholders on the stakeholder committee and
to identify possible differences between groups. As no adequate
questionnaire could be found in the international literature, the
questionnaire had to be developed. The topics and items were based
on an existing checklist [37] and were content validated [38] with
a double Delphi procedure using the content validity index [39].
This process resulted in 36 questions on ﬁve topics: the composi-
tion of the stakeholder committee (3 items), the functioning of the
members of the stakeholder committee (11 items), the function-
ing of the president (5 items), the preparation of the stakeholder
committee (11 questions), and the processes and dynamics within
the stakeholder committee (6 questions). All items were scored
on a 5-point Likert-scale (1 = strongly disagree; 5 = strongly agree).
Next to descriptive results, differences between stakeholder groups
were studied using SPSS
®
[40]. Depending on the distribution of the
data, one-way ANOVA’s or Kruskall-Wallis tests were used with a
signiﬁcance level of 0.05.
In the second phase observations were conducted to identify
additional areas of interest. As no adequate observation tool could
be found, a tool had to be developed based on the available liter-
ature [38]. The observations targeted the same ﬁve topics as the
questionnaire and were conducted by at least three researchers.nvolvement in hospital policy-making: Identifying key elements
6/j.healthpol.2018.02.007
Directly after each observation, researchers’ triangulation was per-
formed to reach consensus on the observations. Recordings of the
observations were made for future use in the study (e.g. listening
and clarifying ambiguities).
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Table  1
Demographic characteristics of the questionnaire’s respondents and response rates in the study.
Variable Presidents and secretaries Internal stakeholders Professional external stakeholders PPI-stakeholders Total
Gender
Male 5 (55.6%) 26 (76.5%) 12 (54.5%) 5 (33.3%) 48 (60.0%)
Female  4 (44.4%) 8(23.5%) 10 (45.5%) 10 (66.7%) 32 (40.0%)
Age
<30  years 0 (0.0%) 0 (0.0%) 0 (0.0%) 3 (20.0%) 3 (3.8%)
30–39  years 1 (11.1%) 4 (11.8%) 4 (18.2%) 3 (20.0%) 12 (15.0%)
40–49  years 2 (22.2%) 8 (23.5%) 4 (18.2%) 3 (20.0%) 17 (21.2%)
50–59  years 3 (33.3%) 18 (52.9%) 10 (45.5%) 4 (26.7%) 35 (43.7%)
60–69  years 0 (0.0%) 4 (11.8%) 4 (18.2%) 2 (13.3%) 10 (12.5%)
>69  years 3 (33.3%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 3 (3.8%)
Education
<bachelor 0 (0.0%) 0 (0.0%) 0 (0.0%) 3 (20.0%) 3 (3.8%)
Bachelor 1 (11.1%) 0 (0.0%) 9 (40.9%) 2 (13.3%) 12 (15.0%)
≥master  8 (88.9%) 34 (100.0%) 13 (59.1%) 10 (66.7%) 65 (81.2%)
Response rate
>2 participationsa 12 (100.0%) 36 (100.0%) 28 (100.0%) 17 (100.0%) 93 (100.0%)
Questionnaire (phase I)b 9 (75.0%) 34 (94.4%) 22 (78.6%) 15 (88.2%) 80 (86.0%)
Observations (phase II) 6 (50.0%) 19 (52.8%) 13 (46.4%) 8 (47.1%) 46 (49.5%)
Focus  groups (phase III) 7 (58.3%) 7 (19.4%) 6 (21.4%) 13 (76.5%) 33 (35.5%)
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ia Number of distributed questionnaires.
b number of persons invited for the focus groups.
In the third phase, the results from the observations and the
uestionnaires were combined to draft a semi-structured focus
roup discussion guide. The focus group discussions were used
o interpret the ﬁndings, reveal underlying processes and identify
dditional conditions for effective PPI. All focus groups were con-
ucted by at least 2 researchers and were recorded. Afterwards,
he recordings were written trans verbatim to be analyzed using
Vivo
®
[41]. The focus groups mainly aimed at identifying under-
ying processes and elements not reported in the questionnaires
nd observations.
.4. Recruitment and data collection
In 2013, general and psychiatric hospitals in Flanders were
nvited to participate in the pilot study. Five general hospitals and
ne psychiatric hospital were purposively selected to implement
he stakeholder committee, based on the variation in hospital set-
ing and the proposed composition of the stakeholder committee.
articipating hospitals had to compose their stakeholder commit-
ee with representatives from all four stakeholder groups. In total,
ne-hundred and sixteen stakeholders were invited by the partici-
ating hospitals and 93 stakeholders participated at least two times
n a stakeholder committee, making them eligible for the study.
ach of these participants received a questionnaire in December
014, resulting in 70 returned questionnaires. Ten observations
ere conducted from September to November 2014 in three of
he six hospitals. Four focus groups were organized in February
015: a focus group for presidents and secretaries, one for internal
takeholders, one for professional external stakeholders, and one
or PPI-stakeholders. Each focus group lasted from one-and-half
o two hours. Table 1 provides an overview of the demographic
haracteristics of the questionnaire’s respondents and the overall
esponse rates.
.5. Ethical considerationsPlease cite this article in press as: Malfait S, et al. Patient and public i
for effective participation. Health Policy (2018), https://doi.org/10.101
The study was approved by the Central Ethics Committee of
blinded for review] and by all local ethics committees of the partic-
pating hospitals. All participants gave a written informed consent.3. Results
In the result section, the essential ﬁndings of the study are given.
An overview of all results can be found the ﬁnal research report [42].
The results are presented in an integrated way, meaning that for
each of the identiﬁed key elements for effective PPI, the results from
different research methods are elaborated and combined. During
the focus groups the results from the questionnaires and observa-
tions (Table 2) were addressed. Four key elements were identiﬁed:
(1) choice of topics and operational issues, (2) proper preparation,
(3) the need for external support, and (4) autonomy of the stake-
holder committee. An overview of these key elements and their
relation to the study ﬁndings are presented in Fig. 2.
3.1. Choice of topics and operational issues
In phase 1 of the study (questionnaires; Table 2), the inter-
nal stakeholders reported they noticed more changes within the
organization as a consequence of the stakeholder committee in
comparison to both PPI-stakeholders and external professional
stakeholders.
The observations (Table 2) made apparent that PPI-stakeholders
took a less active role during the discussions, and internal stake-
holders reacted mostly upon the opinions of the other stakeholders.
The initiative to address the agenda was mostly taken by the secre-
tary as stakeholders did not stimulate each other to formulate their
personal opinion. The goals of the stakeholder committee were
seldomly elaborated at the beginning, and strategic advice was sel-
domly formulated. It was common practice to start the meetings
with the practical issues on the agenda (e.g. adaption of the web-
site and road signs on the hospital campus). These topics were put
on the agenda by both internal stakeholders and PPI-stakeholders.
It became apparent in the focus groups that the exclusive focus
on strategic issues was possibly an ineffective way  for a stake-
holder committee to be initiated. Respondents indicated that all
stakeholders needed time to get acquainted with each other. Oper-nvolvement in hospital policy-making: Identifying key elements
6/j.healthpol.2018.02.007
ational, and thus more practical issues, were perceived as less
threatening than strategic issues. This gave everybody the oppor-
tunity and time to get used to each other, which empowered them
to also undertake discussions on a more strategic level.
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Table 2
Overview of the (selected) results from the ﬁrst phase (questionnaire) and second phase (observations) of the study.
Focus Questionnaire statement Results
Composition of the stakeholder
committee
Demographics Internal stakeholders were higher educated than the group
of  PPI stakeholder (2 = 13.623; df = 3; p = .003)
The stakeholder groups are equally represented in the
stakeholder committee
PPI-stakeholders were less convinced of the fact that they
were represented enough (2 = 10.419; p = .015)
Functioning of the members of the
stakeholder committee
I feel competent to participate in the stakeholder
committee
Respondents with lower education had lower scores
(F  = 0.285; p = .028) felt less competent to participate
I  feel competent to express my  opinion Respondents whit lower education had lower scores
(t  = −2.230; p < 0.001) felt less competent to express their
opinion
Functioning of the president The president was prepared Younger stakeholders had lower scores (F = 3.256; p = .046)
The  president divided speaking time equally under all
the participants
Younger stakeholders had lower scores (F = 4.403; p = .016)
The  president led the discussion Younger stakeholders had lower scores (2 = 15.135;
p < 0.001)
Overall score for the presidents Younger stakeholders had lower scores (2 = 10.621;
p = .005)
Preparation of the stakeholder
committee
The agenda was delivered on time PPI-stakeholders have lower scores (F = 9.155; p < 0.001)
The  documents were delivered on time PPI-stakeholders have lower scores (F = 7.429; p < 0.001)
The  documents contain enough information PPI-stakeholders have lower scores (F = 3.597; p = .018)
The  information in the documents is comprehensive PPI-stakeholders have lower scores (F = 3.658; p = .017)
Processes and dynamics within the
stakeholder committee
I have more information than other stakeholders Internal stakeholders have more information than
PPI-stakeholders (F = 3.38; p = .023)
Based  on the stakeholder committee, there are
changes in the organization
Internal stakeholder report more changes (2 = 13.798;
p  < 0.032) than PPI-stakeholders and external professional
stakeholders
The  stakeholder committee leads to concrete and
practical changes
Younger stakeholders scored lower (2 = 14.181; p = .001)
Changes based on advice were followed-up Younger stakeholders scored lower (2 = 7.114; p = .029)
Focus  Observation
Composition of the stakeholder committee Professional external stakeholder and PPI-stakeholders sit opposite each other
The  number of professional external stakeholders is higher than the number of
PPI
Functioning of the members of the stakeholder committee Internal stakeholders more often respond/react to the opinion of
PPI-stakeholders
The stakeholder groups do not stimulate each other to formulate their own
opinion
PPI-stakeholders take on a passive role
Functioning of the president The president gives no additional background information when this is needed
The  presidents is involved in content discussions making it difﬁcult for PPI to
make a statement
The president is an acquaintance of some of the internal stakeholders.
Preparation of the stakeholder committee The goals of the stakeholder committee are not elaborated at the beginning
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“Big policy decisions. . .we’re  not quite there yet, but I have the
feeling that we’re moving towards it.” [Internal stakeholders focus
group]
Furthermore, PPI-stakeholders indicated that the effects of
trategic changes take longer to become visible, which could
emoralize and discourage them to take further part in the
takeholder committee as they feel non-inﬂuential. They pre-
erred operational issues because of the faster and more visible
uccess, giving them the necessary stimulant. PPI-stakeholders
lso emphasized the importance of including staff nurses in
he stakeholder committee. PPI-stakeholders deﬁne this group
s ‘easy-to-relate-to’ and approachable healthcare workers, often
elated to PPI-stakeholders’ personal problems.Please cite this article in press as: Malfait S, et al. Patient and public i
for effective participation. Health Policy (2018), https://doi.org/10.101
“Personally, I thought that nurses were underrepresented. They are
the most visible connection between us and the hospital.” [PPI-
focus group]During almost all stakeholder committees, no strategic advice was formulated.
Practical topics were put on the agenda by both internal stakeholders and
PPI-stakeholders.
Finally, PPI-stakeholders explained during the focus groups that
the initially proposed topics in the model (e.g. the annual report, the
strategic options and the hospital business plan) were perceived as
distant for PPI-members. PPI-stakeholders indicated having insuf-
ﬁcient knowledge on these topics, and expressed the will to also be
involved in topics that are more related to their personal environ-
ment as they felt to be more expert on those topics.
“For us, the focus of these committees is perhaps less strategic
oriented, but more oriented on the patient as a unique person.”
[PPI-focus group]
All focus groups agreed to the fact that strategic issues were not
discussed, or at least not at the start of the pilot study. Still, none had
the feeling that the project had failed. Overall, stakeholders desig-nvolvement in hospital policy-making: Identifying key elements
6/j.healthpol.2018.02.007
nated time as an essential element for the success of a stakeholder
committee as there should be a personal (e.g. “getting acquainted
with the topics”), interpersonal (“getting to know each other”), and
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rganizational (“from small to big changes”) growth before results
ould be expected.ments for effective PPI.nvolvement in hospital policy-making: Identifying key elements
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“Perhaps one of the most important effects of the stakeholder com-
mittee is that they have introduced patient involvement at the
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highest level of the hospital, perhaps initiating its inclusion in a
hospital culture” [Internal stakeholder focus group]
.2. Proper preparation
The results of the questionnaire (Table 2) showed that the
roup of internal stakeholders was higher educated than the group
f PPI-stakeholders. The latter respondents, with often a lower
ducational level, felt less capable of participating in the stake-
older committee and expressing their opinions. PPI-stakeholders
eported (Table 2) they had the feeling that the agenda and doc-
ments were not delivered in time before the meetings, did not
ontain sufﬁcient information and were not always comprehen-
ive. These results are in contrast with the other stakeholder groups.
oreover, the questionnaires displayed that internal stakeholders
elt that they had more information than the PPI-stakeholders.
In the focus groups, PPI-stakeholders indicated that they have
nsufﬁcient knowledge to cope with strategic questions and inclu-
ion of operational themes was preferred. Next to addressing issues
f a more practical nature, PPI-stakeholders argued that they should
ave the opportunity to thoroughly prepare themselves for the
eetings. Three elements of preparation were mentioned.
First, In order to make sufﬁcient and thorough preparations and
nderstand the topics, important documents and the meeting’s
genda should be delivered well in advance, and should provide
omprehensive and additional information. Often, the topics were
escribed too brieﬂy described, leading to a knowledge gap. Not
ddressing this inequality could compromise the role of the PPI
takeholders.
“It was necessary to receive the necessary documents well in
advance in order to be able to sufﬁciently prepare for the stake-
holder meetings.” [PPI-focus group]
Second, PPI-stakeholders indicated they also needed informa-
ion and training on meetings techniques as PPI-stakeholders felt
ess competent to express their opinions in an organized manner.
Third, receiving information well in advance enabled PPI-
takeholders to consult their peers. This was necessary in order
o have the feeling to express the opinion of a population of peers
nd not solely their own opinion.
“I could not take a stand on some issues as I was only expressing
my own feeling and did not want to be held responsible for the
consequences for everybody.” [PPI-focus group]
.3. External support
The results of the questionnaires (Table 2) indicated that PPI-
takeholders felt underrepresented in comparison to the internal
takeholders. The observations (Table 2) conﬁrmed this feeling.
n all stakeholder committees, internal stakeholders were more
resent than external stakeholders although initially an equal num-
er of stakeholders in each group was anticipated. During the focus
roups, all four stakeholder groups supported the statement that
he group of PPI-stakeholders was too small. The focus groups
ade clear that including more PPI-stakeholders was  difﬁcult as
he ﬁnancial, organizational and staff resources of the supporting
atient organization were insufﬁcient. This is in contrast with the
erceived importance of an organization that was  not afﬁliated to
he government or the hospital as expressed by PPI-stakeholders
uring the focus groups. They deemed the support of an organiza-
ion as essential for three reasons.Please cite this article in press as: Malfait S, et al. Patient and public i
for effective participation. Health Policy (2018), https://doi.org/10.101
First, such organization enabled PPI-stakeholders to reﬂect with
heir peers on a regular bases, giving them the feeling they were
epresenting a whole patient population. An essential element for
PI-stakeholders. PRESS
y xxx (2018) xxx–xxx
“It was useful to have a formal organization that supported us in
making connection with our peers in a structural way” [PPI-focus
group]
Second, such peer groups were also important to provide con-
tinuity. Most participating patients had a chronic illness and could
not always be present due to acute sickness. Peer groups enabled
patients to pass on information to possible substitutes in case of
acute sickness.
Finally, external support by a patient organization was  desig-
nated by the PPI-stakeholders as one of the essential elements
enabling the patients to have a proper preparation for the
stakeholder committee. PPI-stakeholders indicated that this orga-
nization organizes training on meetings techniques and provides
additional content information on hospital topics if needed.
3.4. Autonomy
The results from the questionnaire (Table 2) indicate that
younger stakeholders perceived the president more often as not
well prepared, not dividing speaking time equally, and not ade-
quately leading the discussion. Overall, they judged the actions of
the presidents during the committees less appropriate than the
older age groups. The younger group also felt that the stakeholder
committee did not lead to concrete and practical advice and that
follow-up of their advice was lacking. The observations (Table 2)
showed that the presidents often were acquaintances of the inter-
nal stakeholders. With exception of one hospital, the president used
to be a former internal stakeholder. This often led to involvement
of the president in content discussion, making it difﬁcult, espe-
cially for PPI-stakeholders, to express disagreements or contrasting
opinions and to put new issues on the agenda. This feeling could
be strengthened by the fact that, according to the observations
(Table 2), most meeting rooms were organized in a non-inclusive U-
shape. Consequentially, internal stakeholders and PPI-stakeholders
always took place opposite to each other.
During the focus groups, it was concluded by all stakeholder
groups that PPI is an important topic for the future of healthcare
and hospital policy, especially in competitive environments. It is
perceived as an inevitable future demand of which no escape is
possible.
“It will be, or maybe already is, the duty of hospital to have a form
of accountability to society by including a number of partners.”
[Internal stakeholders focus group]
For all stakeholders it was  important to avoid stakeholders with
no actual impact on hospitals (i.e. instrumentalism). This feeling
was particular present in younger stakeholders. They had a more
critical view towards the stakeholder committee, and more speciﬁc
towards the actions of the president. They regard themselves as the
generation who  will beneﬁt from these initiatives and emphasized
that if, in case of failure to comply with elements of autonomy, the
stakeholder committee will fail and disappear in the hospital. Two
important elements to avoid instrumentalism were mentioned.
First, it became clear that the fact PPI stakeholders were under-
represented in numbers and felt to have insufﬁcient knowledge
and competence. This created the expectancy that the president
would support or protect them during discussions, making the
neutrality of the president important. PPI-stakeholders expressed
their concerns that, if a president does not remain independent
during discussions, the stakeholder committee tends to becomenvolvement in hospital policy-making: Identifying key elements
6/j.healthpol.2018.02.007
instrumental and dependent. If so, PPI-stakeholders will no longer
have the feeling of being involved and actually being heard. These
feelings could make them considering leaving, leading to a non-
representative stakeholder committee.
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“Our president was an independent person, with no connection
to the hospital or any hospital-related organization. Perhaps this
made it easier to express an opinion.” [PPI-focus group]
Second, it was suggested to not legally embed the stakeholder
ommittee in hospital structures. This made the organization of a
takeholder committee a free and deliberate choice, and forces the
ospitals to actually endorse recommendations of their stakeholder
ommittee, making PPI-stakeholders an equal partner. Not endors-
ng recommendations would lead to the disappearance of these
ommittees, and a competitive disadvantage as no PPI will be found
o be part of the stakeholder committee. In case of legally embed-
ing stakeholder committees, the respondents of the focus group
ear that the stakeholder committee will be a formality for most
ospitals, negatively affecting the position of PPI-stakeholders.
“If not [actually endorsed], the stakeholder committee will gather
once a year, purely formal, with no results as a consequence. This
will lead to absenteeism of stakeholders, and ﬁnally extinction. I’m
convinced that the importance of a stakeholder committee will
increase in the near future. (. . .)  It will be a strategic and com-
petitive advantage to have and to retain.” [PPI- focus group]
. Discussion
.1. Explanation of the study ﬁndings
In this study, several interconnected key elements of success-
ully involving patient and the public in hospital policy-making
ould be identiﬁed. In this discussion, each of these key elements
s discussed and put into international perspective.
.1.1. Choice of topics and operational issues
Strategic issues were occasionally discussed during the stake-
older committees although this was the goal of the initial model
29,33], which means an inherent shortcoming within the model.
he study ﬁndings suggest that topics of a more operational nature
hould be addressed (1) to initiate the ﬁrst contact as these are non-
hreatening, (2) to give patients an expert position, (3) to address
opics that are more closely linked to the PPI-stakeholders envi-
onment, (4) to stimulate PPI-involvement, and (5) to address a
ossible problem with the PPI-stakeholders’ feeling of representa-
iveness (e.g. not feeling adequate to represent a population in case
f strategic issues). These ﬁndings match with the ﬁndings of pre-
ious studies on PPI-involvement in research [43] that indicate that
 ﬂexibility in PPI-models on how engagement should take place is
ecessary.
.1.2. Proper preparation
The study shows that a knowledge gap for PPI-stakeholders is to
e bridged before effective PPI-involvement is possible. First, PPI-
takeholders report a lack of competence on meeting techniques.
esearch indicates that lacking such skills could exclude important
PI-groups from participating [20]. Second, PPI-stakeholders report
 lack of knowledge about the functioning of hospitals. In order
o prepare they have to have access to the necessary sources of
nformation. Third, PPI-stakeholders want to discuss possible top-
cs with their peers in order to truly be ‘a representative’. These
hree elements take time. Studies on PPI in research have proven
hat lacking proper preparation leads to feelings of incompetence,
nability or overburdening [22].Please cite this article in press as: Malfait S, et al. Patient and public i
for effective participation. Health Policy (2018), https://doi.org/10.101
.1.3. External support
Next to proper preparation, PPI-stakeholders indicate they lack
he resources to be a true representative. An independent organi-
ation could provide information, support peer groups, and train PRESS
y xxx (2018) xxx–xxx 7
PPI-stakeholders. During this study, there was such a patient orga-
nization, but they indicated a lack in resources to provide the
necessary support for all the PPI-stakeholders. Van de Bovenkamp
et al. [10] have described the necessary, but delicate position of such
organizations. These should professionalize, in order to have sufﬁ-
cient capacity and funds, but should not replace actual patients with
professionalized representatives in order to maintain legitimacy.
4.1.4. Autonomy
International studies [10,16,20] emphasize that citizen par-
ticipation is increasingly important, also in healthcare services.
According to our ﬁndings, PPI is going to be a strategic advan-
tage in the near future and should not be made compulsory. A
similar consideration on the difﬁcult and balanced role of gov-
ernments on not undermining initiatives of PPI with too much
legislation was  expressed previously by Baggot [19]. Our  ﬁndings
suggest that non-legislation could provide in a positive redistribu-
tion effect (e.g. only hospitals with effective PPI-involvement will
ﬁnd PPI-stakeholders for their committee) perhaps resulting in true
autonomy and increased power for stakeholder committees, leav-
ing hospitals with merely instrumental involvement of PPI with no
stakeholder committee at all. The results from younger participants
in this study conﬁrm these future expectations. It is possible that
the societal call for more opportunities to participate was expressed
by this age group as they grew up with these ideals and consider
it as the future paradigm [44]. By not legally embedding the stake-
holder committee, this committee will have increased ownership
and power, making them more autonomous.
When looking at these ﬁndings from the perspective of the
stakeholder theory, which is derived from corporate structures, a
difference can be noticed. The stakeholder theory states that the
salience of a stakeholder is determined by the power, legitimacy
and urgency a stakeholder possesses [45–47]. Based on the discus-
sion above, the identiﬁed conditions for actual involvement seem
strategies mainly aimed at overcoming imbalances of power in
the stakeholder committee. Concerning power imbalances, such
imbalances do exist and are perhaps consciously installed, possibly
reﬂected by the small group of patients and the public in the stake-
holder committees. As pointed out before, interaction between
professionals and patients starts from an inherent power imbalance
as healthcare professionals have a strong professional dominance
over patients due to a comprehensive knowledge on practices and
professional expertise and knowledge [48]. It is only when health-
care professionals have a preparedness to share this power, that
PPI is possible [21,27]. The conditions identiﬁed in this study seem
installed to avoid or overcome such imbalance. The strong empha-
sis on power, and the limited connection to legitimacy and urgency,
indicates that a power shift is the ﬁrst step to be taken in installing
stakeholder committees in hospital settings. Legitimacy is perhaps
addressed less, as patients are the raison d’être of hospitals and
are self-evident [49]. Urgency seems to be lacking, in the behavior
of both hospital- and PPI-stakeholders. This could be an indication
that members of the stakeholder committee are still exploring and
accepting their new roles. This behavior would be similar to patient
participation on the individual level [27]. Overall, great similarities
can be seen with patient involvement on the individual level.
4.2. Contribution to the existing literature/ﬁtting to the existing
literature
Most of the key elements described in this study, have been
partially identiﬁed in the limited amount of previous studies onnvolvement in hospital policy-making: Identifying key elements
6/j.healthpol.2018.02.007
PPI [7,10,16,20,21,43,44]. However, our study further unraveled
the rationale behind these key elements and discussed their pos-
sible relation to power imbalances. Therefore, this study has three
important consequences. First, by providing deeper insight in the
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rocess of effective PPI, future endeavors have more chance on
uccess. From an ethical point of view, as described in the intro-
uction, this is important for not harming the expert position
f patients. These ﬁndings contribute to establishing actual PPI,
voiding instrumentalism and consolidating the equal position that
atients deserve. Second, PPI-involvement on the hospital level
hows to have transnational communalities. Most key elements
dentiﬁed in this study have been reported separately before. This
ndicates that governmental laws and jurisdictions have perhaps a
ore limited effect than previously stated [10]. Third, PPI on a more
ollective level shows strong similarities to patient involvement on
he individual level, indicating that a conceptual framework can be
ased on frameworks from patient involvement and participation
n micro-level.
.3. Recommendations on future research regarding PPI in
ospital policy decision-making
It should be acknowledged that PPI in hospital policy is of grow-
ng importance. The combination of lack in current research on
he topic, the ethical consideration and the popularity of the topic
ndicate that more research is needed [23]. Especially, a concept
nalysis of PPI on hospital level could be useful to provide a common
onceptual framework and scientiﬁc language on the topic [16].
he lack of such a framework has put restraints on the depths of
he analyses of this study. Also, because of possible problems with
he transferability of ﬁndings and policy between countries [49,50],
esearch on PPI initiatives −including this study- is almost exclu-
ively executed in one country. It is important to acknowledge that
his study identiﬁes universal concepts (e.g. proper preparation)
hich are probably identical between modern healthcare systems
nd are less dependent on local legislation, which makes trans-
erability more likely [51]. Thus, future research should target to
mplement a similar intervention in multiple countries, and not be
old aback by concerns about local legislations or transferability.
uch comparative studies are one of the future challenges of the
ealth policy and systems research [12]. Finally, the indication that
ower imbalances, as described on micro-level, are also applicable
nd of great importance to the meso-level can inform future stud-
es on aiming the scope of their analysis towards power imbalances
n the meso-level. As a speciﬁc framework is currently still missing
or analyses [16], frameworks from individual patient-healthcare
orker relationships can be used to guide.
.4. Limitations of the study design
Two points of discussion can be identiﬁed. First, the number
f participants and settings is low which has implications on the
eneralizability of the results. Due to the limited numbers, bias
n representation could be present. In contrast, it could be ethi-
ally hazardous to include a larger sample of hospitals. In case of
egative results, the position of included patients could be nega-
ively affected [27]. Therefore, a pilot study model was  used here.
he deep analyses by using a mixed-methods study design par-
ially overcomes the issue of generalizability by the application of
hick description, which possibly increased the value of the ﬁndings
52]. Still, although the use of mixed-methods studies is increas-
ng, the use in studying healthcare services is still limited [53]. A
erfect method for analyzing and reporting the ﬁndings of mixedPlease cite this article in press as: Malfait S, et al. Patient and public i
for effective participation. Health Policy (2018), https://doi.org/10.101
ethod studies is still in development [12]. Second, this study used
elf-developed tools (e.g. questionnaire and observation checklist)
ecause no applicable tools were available, another indication that
ealthcare service structures are understudied. PRESS
y xxx (2018) xxx–xxx
5. Conclusions
The results of this study conﬁrm that PPI in hospital policy deci-
sion making is a complex process, and should not be taken lightly.
Based on the ﬁndings of this study, four recommendations for effec-
tive and meaningful patient and public involvement on hospital
level can be made. First, PPI on hospital level should also have
the possibility to choose topics and address operational issues and
not merely strategic questions. Second, PPI-stakeholders should
have the resources, knowledge and opportunity to prepare. Third,
PPI-stakeholders should be supported by an external patient orga-
nization. Fourth, the stakeholder committee should be provided
with more autonomy. In the light of increasing civic participation, a
stakeholder committee is expected to become an important asset of
a hospital’s policy and could be a strategic advantage. This strategic
advantage will be minimized if PPI is made compulsory or is being
instrumentalized. Furthermore, this study showed that initiatives
are perhaps less dependent on national legislation than previously
presumed. The conditions presented here are not exhaustive, and
future transnational research is needed. Future research should
also be targeted a providing a conceptual framework which can be,
according on our results, based on model of patient involvement
on the individual level.
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